In silico screening for ERα down modulators identifies thioridazine as an anti-proliferative agent in primary, 4OH-tamoxifen-resistant and Y537S ERα-expressing breast cancer cells.

Autor: Busonero, Claudia1, Leone, Stefano1, Bianchi, Fabrizio2, Acconcia, Filippo1 filippo.acconcia@uniroma3.it
Zdroj: Cellular Oncology (2211-3428). Dec2018, Vol. 41 Issue 6, p677-686. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje